A Novel Second-generation MELK specific inhibitor targets triple negative inflammatory breast cancer (TN-IBC)

Authors

Hector C. Gonzalez, The University of Texas MD Anderson Cancer CenterFollow
Moises J. Tacam, The University of Texas MD Anderson Cancer Center
Mohd Mughees, The University of Texas MD Anderson Cancer Center
Juhyeon Lee, The Uiversity of Texas at Austin
Kevin N. Dalby, The Uiversity of Texas at Austin
Chandra Bartholomeusz, The University of Texas MD Anderson Cancer Center

Files

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston

Keywords

Maternal embryonic leucine zipper kinase (MELK), TNBC, IBC, CSC

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Program Affiliation

Summer Undergraduate Research Program

Recommended Citation

Gonzalez, Hector C.; Tacam, Moises J.; Mughees, Mohd; Lee, Juhyeon; Dalby, Kevin N.; and Bartholomeusz, Chandra, "A Novel Second-generation MELK specific inhibitor targets triple negative inflammatory breast cancer (TN-IBC)" (2021). Summer Experience 2021. 66.
https://openworks.mdanderson.org/sumexp21/66